# FDA Inspection 848685 - Piedmont Reproductive Endocrinology Group, PA - September 05, 2013

Source: https://www.keypedia.com/records/fda_inspections/piedmont-reproductive-endocrinology-group-pa/381af1b7-6dcb-414a-9b8d-53fa2eb7dcdc
Source feed: FDA_Inspections

> FDA Inspection 848685 for Piedmont Reproductive Endocrinology Group, PA on September 05, 2013. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 848685
- Company Name: Piedmont Reproductive Endocrinology Group, PA
- Inspection Date: 2013-09-05
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 991871 - 2016-11-09](https://www.keypedia.com/records/fda_inspections/piedmont-reproductive-endocrinology-group-pa/4048fb9a-1236-4230-ad7a-c181fe1f135f)
- [FDA Inspection 991871 - 2016-11-09](https://www.keypedia.com/records/fda_inspections/piedmont-reproductive-endocrinology-group-pa/bae3358b-47ee-4f3b-834a-59ecfe7eea8f)

Company: https://www.keypedia.com/companies/piedmont-reproductive-endocrinology-group-pa/7fb2a07c-7803-4d82-8f7a-46ee7b73088d

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d